These new therapies have used bortezomib, a proteasome inhibitor that is already approved by the FDA for treatment of multiple myeloma. (sciencedaily.com)
Through its multiple myeloma initiative and other grant programs, CRI is supporting several basic and clinical studies that are advancing the understanding and immunologic treatment of multiple myeloma. (cancerresearch.org)
At present, he is leading multiple efforts studying the use of new agents and pioneered the development of lenalidomide, bortezomib, and dexamethasone (so called RVD), which is now widely used in the upfront treatment of multiple myeloma. (warrenalpert.org)